Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:estrogen receptor status - clinical trial eligibility criteria'
(id=8994096 ; fe=en:estrogen receptor status - clinical trial eligibility criteria ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=757 creation date=2017-10-07 touchdate=2025-07-16 16:19:49.000)
≈ 37 relations sortantes

  1. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 43 / 1 -> en:egfr positive
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:egfr positive | rel=r_associated | relid=0 | w=43
  2. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 40 / 0.93 -> en:estrogen receptor positive
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:estrogen receptor positive | rel=r_associated | relid=0 | w=40
  3. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 37 / 0.86 -> en:androgen receptor positive
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:androgen receptor positive | rel=r_associated | relid=0 | w=37
  4. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 36 / 0.837 -> en:cd70 positive
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:cd70 positive | rel=r_associated | relid=0 | w=36
  5. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 36 / 0.837 -> en:interleukin-3 receptor subunit alpha positive
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:interleukin-3 receptor subunit alpha positive | rel=r_associated | relid=0 | w=36
  6. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 36 / 0.837 -> en:nr3c1 positive
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:nr3c1 positive | rel=r_associated | relid=0 | w=36
  7. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 36 / 0.837 -> en:ptprc positive
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:ptprc positive | rel=r_associated | relid=0 | w=36
  8. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 35 / 0.814 -> en:estrogen receptor status
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:estrogen receptor status | rel=r_associated | relid=0 | w=35
  9. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 35 / 0.814 -> en:somatostatin receptor positive
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:somatostatin receptor positive | rel=r_associated | relid=0 | w=35
  10. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 34 / 0.791 -> en:triple-negative breast cancer finding
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:triple-negative breast cancer finding | rel=r_associated | relid=0 | w=34
  11. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 32 / 0.744 -> en:fcer2 positive
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:fcer2 positive | rel=r_associated | relid=0 | w=32
  12. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 29 / 0.674 -> en:alk negative
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:alk negative | rel=r_associated | relid=0 | w=29
  13. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 29 / 0.674 -> en:alk positive
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:alk positive | rel=r_associated | relid=0 | w=29
  14. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 29 / 0.674 -> en:esr1 gene
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:esr1 gene | rel=r_associated | relid=0 | w=29
  15. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 29 / 0.674 -> en:estrogen receptor and/or progesterone receptor positive
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:estrogen receptor and/or progesterone receptor positive | rel=r_associated | relid=0 | w=29
  16. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 28 / 0.651 -> en:fcer2 negative
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:fcer2 negative | rel=r_associated | relid=0 | w=28
  17. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 28 / 0.651 -> en:il2ra positive
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:il2ra positive | rel=r_associated | relid=0 | w=28
  18. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 28 / 0.651 -> en:pdgfra positive
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:pdgfra positive | rel=r_associated | relid=0 | w=28
  19. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 28 / 0.651 -> en:receptor overall status
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:receptor overall status | rel=r_associated | relid=0 | w=28
  20. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 28 / 0.651 -> en:tnfrsf17 positive
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:tnfrsf17 positive | rel=r_associated | relid=0 | w=28
  21. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 28 / 0.651 -> en:tnfrsf8 low
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:tnfrsf8 low | rel=r_associated | relid=0 | w=28
  22. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 28 / 0.651 -> en:tnfrsf8 positive
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:tnfrsf8 positive | rel=r_associated | relid=0 | w=28
  23. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 27 / 0.628 -> en:encounter due to estrogen receptor status
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:encounter due to estrogen receptor status | rel=r_associated | relid=0 | w=27
  24. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 27 / 0.628 -> en:estrogen receptor negative
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:estrogen receptor negative | rel=r_associated | relid=0 | w=27
  25. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 27 / 0.628 -> en:fgfr2 positive
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:fgfr2 positive | rel=r_associated | relid=0 | w=27
  26. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 27 / 0.628 -> en:hormone receptor/her2 positive
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:hormone receptor/her2 positive | rel=r_associated | relid=0 | w=27
  27. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 27 / 0.628 -> en:kdr positive
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:kdr positive | rel=r_associated | relid=0 | w=27
  28. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 26 / 0.605 -> en:folate receptor alpha positive
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:folate receptor alpha positive | rel=r_associated | relid=0 | w=26
  29. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 26 / 0.605 -> en:her2/neu status
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:her2/neu status | rel=r_associated | relid=0 | w=26
  30. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 26 / 0.605 -> en:igf1r positive
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:igf1r positive | rel=r_associated | relid=0 | w=26
  31. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 26 / 0.605 -> en:progesterone receptor status
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:progesterone receptor status | rel=r_associated | relid=0 | w=26
  32. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 25 / 0.581 -> en:estrogen
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:estrogen | rel=r_associated | relid=0 | w=25
  33. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 25 / 0.581 -> en:estrogen receptor
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:estrogen receptor | rel=r_associated | relid=0 | w=25
  34. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 25 / 0.581 -> récepteur
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=récepteur | rel=r_associated | relid=0 | w=25
  35. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 20 / 0.465 -> en:androgen receptor status
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:androgen receptor status | rel=r_associated | relid=0 | w=20
  36. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 20 / 0.465 -> en:egfr negative
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:egfr negative | rel=r_associated | relid=0 | w=20
  37. en:estrogen receptor status - clinical trial eligibility criteria -- r_associated #0: 1 / 0.023 -> en:clinical attribute
    n1=en:estrogen receptor status - clinical trial eligibility criteria | n2=en:clinical attribute | rel=r_associated | relid=0 | w=1
≈ 31 relations entrantes

  1. en:egfr positive --- r_associated #0: 31 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:egfr positive | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=31
  2. en:her2/neu status --- r_associated #0: 31 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:her2/neu status | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=31
  3. en:androgen receptor positive --- r_associated #0: 29 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:androgen receptor positive | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=29
  4. en:egfr negative --- r_associated #0: 27 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:egfr negative | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=27
  5. en:estrogen receptor status --- r_associated #0: 27 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:estrogen receptor status | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=27
  6. en:androgen receptor status --- r_associated #0: 26 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:androgen receptor status | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=26
  7. en:progesterone receptor status --- r_associated #0: 26 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:progesterone receptor status | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=26
  8. en:alk negative --- r_associated #0: 20 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:alk negative | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=20
  9. en:alk positive --- r_associated #0: 20 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:alk positive | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=20
  10. en:encounter due to estrogen receptor status --- r_associated #0: 20 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:encounter due to estrogen receptor status | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=20
  11. en:esr1 gene --- r_associated #0: 20 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:esr1 gene | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=20
  12. en:estrogen receptor and/or progesterone receptor positive --- r_associated #0: 20 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:estrogen receptor and/or progesterone receptor positive | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=20
  13. en:estrogen receptor negative --- r_associated #0: 20 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:estrogen receptor negative | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=20
  14. en:estrogen receptor positive --- r_associated #0: 20 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:estrogen receptor positive | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=20
  15. en:fcer2 negative --- r_associated #0: 20 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:fcer2 negative | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=20
  16. en:fcer2 positive --- r_associated #0: 20 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:fcer2 positive | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=20
  17. en:fgfr2 positive --- r_associated #0: 20 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:fgfr2 positive | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=20
  18. en:folate receptor alpha positive --- r_associated #0: 20 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:folate receptor alpha positive | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=20
  19. en:hormone receptor/her2 positive --- r_associated #0: 20 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:hormone receptor/her2 positive | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=20
  20. en:igf1r positive --- r_associated #0: 20 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:igf1r positive | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=20
  21. en:il2ra positive --- r_associated #0: 20 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:il2ra positive | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=20
  22. en:kdr positive --- r_associated #0: 20 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:kdr positive | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=20
  23. en:pdgfra positive --- r_associated #0: 20 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:pdgfra positive | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=20
  24. en:receptor overall status --- r_associated #0: 20 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:receptor overall status | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=20
  25. en:somatostatin receptor positive --- r_associated #0: 20 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:somatostatin receptor positive | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=20
  26. en:tnfrsf17 positive --- r_associated #0: 20 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:tnfrsf17 positive | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=20
  27. en:tnfrsf8 low --- r_associated #0: 20 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:tnfrsf8 low | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=20
  28. en:tnfrsf8 positive --- r_associated #0: 20 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:tnfrsf8 positive | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=20
  29. en:triple-negative breast cancer finding --- r_associated #0: 20 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=en:triple-negative breast cancer finding | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=20
  30. récepteur des androgènes positif --- r_associated #0: 10 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=récepteur des androgènes positif | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=10
  31. statut du récepteur des androgènes --- r_associated #0: 10 --> en:estrogen receptor status - clinical trial eligibility criteria
    n1=statut du récepteur des androgènes | n2=en:estrogen receptor status - clinical trial eligibility criteria | rel=r_associated | relid=0 | w=10
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr